avelumab
B9991040
Phase 2 small_molecule terminated
Quick answer
avelumab for Squamous Cell Carcinoma of the Head and Neck (SCCHN) is a Phase 2 program (small_molecule) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated